Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
154.14
-0.08 (-0.05%)
At close: May 12, 2025, 4:00 PM
154.16
+0.02 (0.01%)
After-hours: May 12, 2025, 7:50 PM EDT
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $21.89B in the quarter ending March 30, 2025, with 2.39% growth. This brings the company's revenue in the last twelve months to $89.33B, up 4.30% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$89.33B
Revenue Growth
+4.30%
P/S Ratio
4.15
Revenue / Employee
$646,857
Employees
138,100
Market Cap
370.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
Thermo Fisher Scientific | 42.90B |
JNJ News
- 1 hour ago - 50 Fortune World's Most Admired Companies (FWMAC): 24 "Safer", 1 Ideal Buy - Seeking Alpha
- 4 hours ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 4 hours ago - Johnson & Johnson: For Those Who Want Some Immunity Against Tariff Changes - Seeking Alpha
- 5 hours ago - 10 stocks for a high-tariff world - Market Watch
- 6 hours ago - Drugmakers are spared worst-case drug pricing scenario for now - WSJ
- 7 hours ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 8 hours ago - Trump says executive order will slash the cost of prescription drugs - Business Insider
- 14 hours ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ